Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 15/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3584986 | 0.90 | HRH3 (0.52) | HRH3NPC1RAB9A | |
| SCHEMBL3575387 | 0.88 | HRH3 (0.50) | HRH3KCNH2 | |
| SCHEMBL3575679 | 0.84 | HRH3 (0.51) | HRH3KCNH2 | |
| SCHEMBL3579817 | 0.81 | HRH3 (0.57) | HRH3NPC1RAB9AKCNH2 | |
| SCHEMBL3582456 | 0.81 | HRH3 (0.53) | HRH3NPC1RAB9A | |
| SCHEMBL3584805 | 0.80 | HRH3 (0.52) | HRH3NPC1RAB9AKCNH2 | |
| SCHEMBL4047116 | 0.79 | HRH3 (0.59) | HRH3NPC1RAB9AKCNH2 | |
| SCHEMBL3589140 | 0.79 | HRH3 (0.54) | HRH3KCNH2 | |
| SCHEMBL3579676 | 0.79 | HRH3 (0.55) | HRH3KCNH2 | |
| SCHEMBL3581861 | 0.79 | HRH3 (0.55) | HRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049548-A1 | FUSED OXAZOLES & THIAZOLES AS HISTAMINE H3- RECEPTOR LIGANDS | UCB Pharma, S.A. (BE) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008012010-A1 | FUSED OXAZOLES & THIAZOLES AS HISTAMINE H3- RECEPTOR LIGANDS | UCB PHARMA, S.A. (BE) | 2008-01-31 | — | — | WO | disclosed |